Baxdrostat is a highly selective, second-generation, nonimidazole aldosterone synthase inhibitor; 100 times less baxdrostat ...

All individuals with hypertension should be screened for primary aldosteronism (PA), according to a clinical practice guideline.

Even in people without high blood pressure, subclinical primary aldosteronism is linked to a significantly higher risk for ...

Doctors are regularly overlooking a common hormone-driven cause of high blood pressure -- primary aldosteronism -- ...

AstraZeneca announced that baxdrostat, a selective aldosterone synthase inhibitor, met its primary and all secondary ...

An international team of researchers led by Professor Morris Brown FRS at Queen Mary University of London found that ...

Renal replacement therapy prolongs life in patients with Stage 5 chronic kidney disease. Сardiovascular diseases are the main ...

Watch this excited service dog get a well-deserved new toy after he saved his owner's life in the middle of the night!

A phase 2 trial evaluated the efficacy and safety of lorundrostat in hypertensive patients with chronic kidney disease (CKD) and albuminuria.

Method: Add all ingredients to a saucepan with 2 cups of water. Bring to a boil, then reduce to simmer for 5-7 minutes.

Baxdrostat meets primary and all secondary endpoints in BaxHTN phase III trial in patients with uncontrolled or treatment resistant hypertension: Cambridge, UK Wednesday, July 16, ...